HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


COVID-19 Fraud In US: Online Pharmacies Promote HIV Drug, Ammo Dealer Pitches Vitamin C

Executive Summary

Latest letters from website reviews push to 62 the number of warnings the FDA, either jointly with the FTC or on its own, has made stating that no drug has yet been approved by the agency for use in the prevention, diagnosis, treatment, mitigation or cure of COVID-19.

You may also be interested in...

Twin Websites Selling Steroids OTC Also Offered HIV, Influenza Drugs As COVID-19 Treatments

Two e-commerce sites offering steroids OTC also were offering HIV and influenza drugs as treatments for COVID-19, according to FDA warnings. The listings have been removed but the operators were asked to provide plans to remedy violations within 48 hours.

Like Other Outbreaks, Coronavirus Symptoms Include False Health Claims, Price-Gouging

FDA isn't alone monitoring drug, medical device and food companies making false Covid-19 treatment claims. New York AG warns Jim Bakker, UK agency cuts off face mask ads, Amazon removes thousands of products priced to cheat fearful consumers and Facebook cuts false ads.

Sales Of Injectable CBD Offered OTC In US Stop With Recall; ChapStick, Benefiber Also Recalled

Recent US consumer health and beauty product recalls also include three shades of lip moisturizer with sunscreen, made by Pfizer and marketed by GSK due to a packaging problem. A Florida firm recalled one lot of a CBD oil tincture after a state agency’s test found high lead levels.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts